-
公开(公告)号:US20240192197A1
公开(公告)日:2024-06-13
申请号:US18554490
申请日:2022-04-07
Inventor: Hai JIANG , Shishuang CHEN , Yankai CHU
CPC classification number: G01N33/5023 , C07K14/4747 , C07K2319/70 , G01N2333/46 , G01N2500/10
Abstract: Provided is a novel screening system for a drug target antagonist based on cell life/death phenotype. Specifically, on the basis of a target protein and a conditional suicide protein FKBP 12 (F36V)-Caspase9, a screening system is designed for screening a target protein inhibitor or a degradation agent. The screening system is stable and efficient, the phenotype is obviously easy to observe, and the screening system can be used for high-throughput screening.
-
22.
公开(公告)号:US20230305187A1
公开(公告)日:2023-09-28
申请号:US18041497
申请日:2021-07-13
Applicant: Pei Chen , Rui Liu , Center for Excellence in Molecular Cell Science, Chinese Academy of Sciences
Inventor: Luonan Chen , Pei Chen , Rui Liu
IPC: G01W1/02
CPC classification number: G01W1/02
Abstract: The invention discloses a multi-step prediction method and system of future wind speed based on automatic reservoir neural network, realizes accurate and fast multi-step prediction of future information, maintains high robustness to noise and system time-varying, and avoids over-fitting problems. The technical scheme is: for short-term high-dimensional wind speed data, based on the delay embedding theory, the observed high-dimensional dynamics is used as the reservoir by using space-time information transformation, and the high-dimensional wind speed data is mapped to the future information of the target variable. The automatic reservoir neural network realizes the multi-step prediction of the target variable by solving a pair of conjugate space-time information interaction equations.
-
公开(公告)号:US20220243270A1
公开(公告)日:2022-08-04
申请号:US17433568
申请日:2019-12-10
Inventor: Lingling CHEN , Li YANG , Chuxiao LIU , Xiang LI , Fang NAN
IPC: C12Q1/6883 , A61K45/06 , A61K31/713 , A61P37/02
Abstract: The present invention provides use of a circular RNA with an incomplete double-stranded structure of 16 bp-33 bp in length and/or a promoting agent of the circular RNA with an incomplete double-stranded structure of 16 bp-33 bp in length in preparation of a medicament for treating systemic lupus erythematosus.
-
-